ATC code R
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by The Anome (talk | contribs) at 09:15, 22 August 2023 (Importing Wikidata short description: "Section of Anatomical Therapeutic Chemical Classification System relating to drugs affecting the respiratory system"). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.Revision as of 09:15, 22 August 2023 by The Anome (talk | contribs) (Importing Wikidata short description: "Section of Anatomical Therapeutic Chemical Classification System relating to drugs affecting the respiratory system")
Section of Anatomical Therapeutic Chemical Classification System relating to drugs affecting the respiratory system
Pharmaceutical drug classification
ATC code R: Respiratory system |
---|
|
Other ATC codes |
ATC code R Respiratory system is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3][4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QR.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
References
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code R". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QR". WHO Collaborating Centre for Drug Statistics Methodology.
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System | |
---|---|
gastrointestinal tract / metabolism (A) | |
blood and blood forming organs (B) | |
cardiovascular system (C) | |
skin (D) | |
genitourinary system (G) | |
endocrine system (H) | |
infections and infestations (J, P, QI) | |
malignant disease (L01–L02) | |
immune disease (L03–L04) | |
muscles, bones, and joints (M) | |
brain and nervous system (N) |
|
respiratory system (R) | |
sensory organs (S) | |
other ATC (V) | |
Decongestants and other nasal preparations (R01) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Topical |
| ||||||||||
Systemic use: Sympathomimetics | |||||||||||
|
Expectorants | |||||
---|---|---|---|---|---|
Mucolytics | |||||
Cough suppressants |
| ||||
|
Benzimidazoles (*) | |
---|---|
Diarylmethanes |
|
Ethylenediamines | |
Tricyclics | |
Others |
|
For topical use |
Other respiratory system products (R07) | |
---|---|
Lung surfactants | |
Respiratory stimulants | |
5-HT4 receptor agonists | |
Other agents for treating respiratory depression |